Transformation of veterinary pharmaceuticals and biocides in liquid manure

Veterinary medicinal products administered to animals are excreted with urine and faeces. For animals housed in stables, the resulting manure is collected and stored before being spread onto agricultural land. Disinfection products used to sanitize stables are also transferred into the manure. Therefore, the spreading of manure is an important pathway of introducing veterinary medicines, […]

Intelligence-led Assessment of Pharmaceuticals in the Environment (iPiE)

Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]

Comparison of the environmental properties of parasiticides and harmonisation of the basis for environmental assessment at the EU level

Avermectin and milbemycin parasiticides have a high toxicity to non-target organisms, are often persistent and may have a potential to bioaccumulate. The present project contributes to filling gaps in the database for a complete environmental risk assessment of these parasiticides. In addition, risk management strategies for parasiticides used in pasture animals were discussed. For ivermectin […]

Necessity of testing biocidal products and their eluates within the authorization process aiming at an adequate environmental evaluation of mixtures – Extending the database for wood preservatives.

In the authorization process of biocidal products, the joint effects of the product components (active substances and relevant additives) shall be taken into account in the environmental risk assessment according to the relevant regulatory guidance. The concept of concentration addition (CA) is the proposed default model for this assessment. Open questions in this context are […]

Joint effects of pharmaceuticals and industrial chemicals from wastewater treatment plant effluents – evaluating concepts for a risk assessment using experimental scenarios

The aim of this project is to develop and evaluate concepts for a risk assessment of wastewater effluents taking into account the joint effects of chemicals, which are not completely eliminated in the wastewater treatment process. The focus is on pharmaceutical residues and industrial chemicals, particularly those that are frequently detected in effluents. The predictability […]

Characterization, communication and minimization of risks originating from emerging contaminants and pathogens in the water cycle (TransRisk)

The presence of emerging contaminants and pathogens in the water cycle may pose a risk to humans and the environment. It is known that municipal wastewater treatment plants currently cannot remove all pathogens and anthropogenic micropollutants such as drug residues, cosmetics, or additives of food and industrial products from the wastewater. Advanced treatment methods such […]

Selection of test organisms for the environmental risk assessment of genetically modified plants: applying and testing a new selection procedure

Since almost two decades now, chemical stressors such as pesticides are subjected to a number of standardised ecotoxicity tests for regulatory approval prior to their release to the environment. Since the advent of the technology, genetically modified organisms (GMOs) in general, and genetically modified plants (GMPs) in particular have been a contentious issue  and, very […]

Development of effective measures to reduce the environmental risk of human and veterinary pharmaceuticals

The environmental risks related to human and veterinary pharmaceuticals have to be assessed according to legal requirements within the authorisation procedures for pharmaceuticals. If a risk for the environment is indicated, risk mitigation measures should be proposed by the applicant and implemented within the risk management. The authorisation of a veterinary pharmaceutical can be refused […]

Ecotoxicological joint effects of mixtures – relevance and appropriate consideration in the environmental risk assessment of plant protection products and biocides

The aim of this project was to assess the relevance of joint effects related to plant protection products and biocidal products. Based on a general analysis of the concepts of mixture toxicity and their application, as well as a detailed analysis of the current environmental risk assessment schemes and their limitations, options were developed for […]

Investigation of sublethal endpoints in dung organisms as a prerequisite for the implementation of terrestrial ecotoxicological studies within the environmental risk assessment of veterinary pharmaceuticals

The aims of this project were the compilation and publication of the results of workshops with international dung fauna experts (Aveiro group) and the further improvement of existing laboratory tests with dung beetles and dung flies. Two publications were prepared: first, recommendations for the preparation, performance and assessment of field studies with dung organisms, and […]